Abstract Details

Title Long-Term Efficacy and Tolerability of Milnacipran: 3-Year Results from an Open-Label, Flexible-Dosing Study in Patients with Fibromyalgia

Topic Ethics, Pain and Palliative Care

Presentation(s) (-)

Poster/Presentation
Number 269

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Lesley M. Arnold, MD	No disclosure on file
	No disclosure on file
Marc Wonneberger (Bundesinstitut Fur Sportwissenschaft)	No disclosure on file
Joel M. Trugman, MD, FAAN	Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
	No disclosure on file
Kimberley M. Thacker, MD	No disclosure on file
	No disclosure on file

��ɫ��